Vitalhub Corp (VHI.TO) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Technology · Canada · ISIN CA92847V5018

Price
7.71 CAD
Market cap
464.82 m CAD
P/E (2025)
76.06
P/S (2025)
4.27
Dividend yield
0.00 %
Net margin
5.61 %
Return on equity (ROE)
2.30 %
Return on assets (ROA)
1.73 %

Vitalhub Corp financials

Fiscal year20242025
Revenue68.59 m CAD108.97 m CAD
Gross profit55.49 m CAD76.51 m CAD
Operating income9.74 m CAD12.17 m CAD
EBIT5.94 m CAD5.97 m CAD
Net income3.00 m CAD6.11 m CAD
Diluted EPS – continuing operations0.06 CAD0.10 CAD

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Vitalhub Corp

Vitalhub Corp., together with its subsidiaries, provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. The company offers patient flow, operational visibility, and patient journey optimization solutions for hospital and integrated health environments, including SHREWD, Intouch with Health, Strata Health, MedCurrent, Beautiful Information, My Pathway, BookWise Solutions, Jayex Acute, MCAP, and Oculys. It also provides electronic healthcare record, case management, care coordination, and optimization solutions to inpatient/outpatient care providers, long-term care, and community and social services focused organizations, such as TREAT, CaseWORKS, clarity, Community Data Solutions, S12, B Care, DOCit, hicom, Clarity Healthcare Solutions, and Pirouette. In addition, the company offers a workforce automation and compliance suite that integrates and centralizes workforce and compliance data, which includes Hicom, Premier IT, and BookWise. Vitalhub Corp. was founded in 2010 and is headquartered in Toronto, Canada.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.